Biotech Values

[iwfal]

ABT HCV results:

Agreed that these look good - but:

a) Reminder that previous data indicated that for an ABT all-oral regimen (this one?) the post treatment relapse rate was much greater than one would expect from an ifn based treatment - even past 24 weeks.


b) I'd like to see a breakout of G1a vs G1b

In combo I would guess there is still substantial room for improvement in one of the G1 subtypes.